Guidelines to author
World journal of pharmaceutical sciences (An international peer-reviewed monthly journal) publishes original articles, critical reviews, case studies and short communications in the field of Pharmaceutical sciences. It allows free unlimited access to abstract and full-text. The journal policy is to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field. Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal.
SUBMISSION OF THE MANUSCRIPT
In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party. All submissions must be in the English and should be submitted by the online submission system. Each manuscript will be provided with a manuscript ID and all correspondence is done through e-mail. Please always refer to the manuscript ID for any further enquiries. Authors are invited to suggest up to five potential reviewers, together with their contact details (e-mail addresses are essential). In case of any problem through the online submission, submit manuscripts to our mail: email@example.com and firstname.lastname@example.org preferably by the corresponding author.
TYPE OF MANUSCRIPT
Original Article: It should consist of unpublished results of original research, which must be presented in detail to comply the reproducibility of the described experiments and desired output. This research article should reveal design of experimental studies that gives a significant contribution to knowledge. Review Article: Review articles should not be more than 16 pages and contain comprehensive coverage of relevant literature. Review articles should preferably be written by scientists who have in-depth knowledge of the topic. All format requirements are similar to those applicable to original article. Review articles need not to be divided into sections such as Materials and methods, and Results and discussion, but should definitely have an abstract and introduction. Short Communication: The research and technical communications section of this journal (maximum 3,000 words) is open to interesting results worthy of publication without requiring extensive introduction and discussion. This section should be organized as follows: Abstract, Introduction, Materials and methods, Results and discussion (combined). Not more than 10 references should be provided. Tables, figures and references are to be arranged in the same way as for research papers. Brevity of presentation is essential for this section. Case Studies: They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority. These communications could be of up to 1800 words (excluding Abstract and references) and should have the following headings: Abstract (unstructured), Key-words, Introduction, and Case report, Discussion, Reference, Tables and Legends in that order. They could be supported with up to 20 references. Case Reports could be authored by up to six authors.
Manuscript preparation: The manuscript should be prepared in English using “MS Word” with 1 inch margin on all sides of the page. “Times New Roman” font should be used. The font size should be of 12pt but main Title should be of 14pt bold uppercase, main headings should be of 12pt bold uppercase, subheadings should be of 12pt bold lowercase. These subtitles should be typed in italics. Illustrations (Figures & Graphs) and tables must be inserted at the end of the reference section. Manuscript should be concisely typewritten in 1.5 spaces in A4 sized sheets. The length of article should not exceed 25 pages to include figures, tables and references. No abbreviations on acronyms shall be used in the titles or Abstract acronyms except for measurements. There shall not be decorative borders anywhere in the text including the title page. These entire MS word document with graphs and illustration pasted in it shall not exceed 4 MB. The manuscript should be starting with the covering letter and the text should be arranged in the following order:
- Covering letter
- Title Page
- Materials and Methods
- Results and Discussion
- Acknowledgements (If any)
- Figures and/or Graphs
Covering letter: The corresponding author should mention the undertaking that if any animal studies carried was in accordance with their country or institutional ethical committee and also state that the manuscript has not been published elsewhere or even under consideration for publication.
Title Page: The title must be as brief as possible, comprehensive and descriptive. It should not be more than 20 words. Title should be of 14pt bold uppercase. Each author must provide their full name including their forenames and surname. The Corresponding Author of the manuscript must be marked with an asterisk. In addition the corresponding author must include Telephone and E-mail address at the bottom left corner of the title page. If any of the co-authors are from different organizations, their addresses too should be mentioned and indicated using numbers after their names. Maximum 6 authors should be allowed.
Abstract: Provide on a separate page an abstract of not more than 200 words. A concise and factual abstract is required. The Abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, standard nomenclature should be used and abbreviations and references should be avoided.
Keywords: Provide four to ten appropriate key words after abstract will help readers or indexing agencies in cross-indexing the study. Use terms from the latest Medical Subject Headings (MeSH) list of Index Medicus. A more general term may be used if a suitable MeSH term is not available. The words found in title need not be given as key words.
Introduction: The introduction should not be an extensive literature review although it should provide sufficient background information for the reader to understand and evaluate the results of the present study and it should start on a new page. Justification for research aims and objectives must be clearly mentioned without any ambiguity. The purpose of the study should be stated at the end. The introduction MUST include in-text citations including references to pertinent reviews and primary scientific literature.
Materials and Methods: It should be complete enough to allow experiments to be reproduced. However, only new procedures should be described in detail, previously published procedures should be cited, and important modifications of published procedures should be mentioned briefly. Capitalize trade names and include the manufacturer's name and address. Subheadings should be used. Methods in general use need not be described in detail. All important materials used along with their source shall be mentioned. Please include the company sources for all uncommon reagents (kits, drugs, etc). Drugs and chemicals should be precisely identified using their non-proprietary names or generic names.
Results: The results should be stated concisely without comments. They should be presented in logical sequence in the text with appropriate reference to tables and/or figures. The data given in tables or figures should not be repeated in the text. The same data should not be presented in both tabular and graphic forms. Simple data may be given in the text itself instead of figures or tables.
Discussion: This section should follow results, deal with the interpretation of results, convey how they help increase current understanding of the scientific problems being investigated in the field and should be logical. Description of relevant references to other work/s in the field should be included here. This section also allows you to discuss the significance of your results - i.e. does the data support the hypotheses you set out to test? Unsupported hypothesis should be avoided. This section should end with new answers/questions that arise as a result of your work. Sometimes the results and discussion can also be combined under one section.
Conclusion: It must be drawn considering the strengths and weaknesses of the study. This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance.
Acknowledgments: The source of any financial support, gifts, technical assistance and advice received for the work being published must be indicated in the Acknowledgments section.
References: The authors are responsible for the accuracy of the bibliographic information. It must be numbered consecutively in the order that they are cited in the text. Arabic numerals (ENCLOSED IN SQUARED BRACKETS, eg., , [1,3,5] or [1-4]) should be used in citing references in the text. The squared brackets MUST NOT be used anywhere else in the text to allow easy xml file coding. A list should be included on separate double-spaced pages at the end of the text. For the proper abbreviations of the journal titles, refer to “Chemical Abstracts”. The style and punctuation of the references should confirm to
the following examples: Journal references
One author: Abada EA. Isolation and characterization of antimicrobial compound from Bacillus coagulans. Anim Cells Syst 2008; 12:41-6.
Two authors: Vu-Duc T, Vernay A. Simultaneous detection and quantitation of O6-monoacetylmorphine, morphine and codeine in urine by gas chromatography with nitrogen specific and/or flame ionization detection. Biomed Chromatogr 1990; 4(2): 65–9.
Three or more authors: Moran GJ et al. Methicillinresistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005; 11: 928-30.
Article in press: Ladines CA et al. Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 2008 (in press).
Electronic publication ahead of print: Teeuwen PHE. Doppler-guided intra-operative fluid management during major abdominal surgery: a systematic review and meta-analysis. Int J Clin Pract (accessed 21 November 2007, epub ahead of print).
Corporate author: The Cardiac Society of Australia and New Zealand. Clinical exercise stress testing. Safety and performance guidelines. Med J Aust 1996; 164: 282-4.
Article not in English: Sokolov S et al. [Studies of neurotropic activity of new compounds isolated from Rhodiola rosea L. Khim Farm Zh 1985; 19: 1367–1371 [in Russian]
Book by a single author: Crabtree RH. The Organometallic Chemistry of the Transition Metals, 3rd ed.; Wiley & Sons: New York, 2001.
An edited book: Ford HL, Sclafani RA, Degregori J. Cell Cycle Regulatory Casacade. In: Cell Cycle and Growth Control: Bimolecular Regulation and Cancer, 2nd ed, Stein GS, Pardee AB, Eds; Wiley- Liss: Hoboken, NJ, 2004; pp. 42-67.
An article in an edited book: Sanders PA. Aerosol packaging of pharmaceuticals. In: Banker GS, Rhodes CT, eds. Modern Pharmaceutics. New York: Marcel Dekker, 1979: 591–626.
Conference Proceedings Jakeman DL, Withers SGE. In: Carbohydrate Bioengineering: Interdisciplinary Approaches, Proceedings of the 4th Carbohydrate Bioengineering Meeting, Stockholm, Sweden, June 10-13, 2001; Teeri TT, Svensson B, Gilbert HJ, Feizi T, Eds; Royal Society of Chemistry: Cambridge, UK, 2002; pp. 3-8.
Patents Hoch JA, Huang S. Screening methods for the identification of novel antibiotics. U.S. Patent 6,043,045, March 28, 2000.
Websites National Library of Medicine. Specialized Information Services: Toxicology and Environmental Health. http://sis.nlm.nih.gov/Tox/ToxMain.html (Accessed May 23, 2004).
Thesis Mackel H. Capturing the Spectra of Silicon Solar Cells. PhD Thesis, The Australian National University: Canberra, December 2004.
For other types of citation, please see “Uniform Requirement for Manuscripts Submitted to Biomedical Journals: Sample References” at www.nlm.nih.gov/bsd/uniform_requirements.html
Tables: Should be typed on separate sheets of paper and should not preferably contain any molecular structures. Only MS word table format should be used for preparing tables. Tables should show lines separating columns but not those separating rows except for the top row that shows column captions. Tables should be numbered consecutively in Arabic numerals and bear a brief title in capital letters normal face. Units of measurement should be abbreviated and placed below the column headings. Column headings or captions shall be in bold face. It is essential that all tables have legends, which explain the contents of the table and place footnotes to tables below the table body. Tables should not be very large that they run more than one A4 sized page. Tables should not be prepared in the landscape format, i. e. tables that are prepared widthwise on the paper. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.
Figures: Should be on separate pages but not inserted within the text. Figures should be numbered consecutively in Arabic numerals and bear a brief title in lower case bold face letters below the figure. Graphs and bar graphs should preferably be prepared using Microsoft Excel and submitted as Excel graph pasted in Word. These graphs and illustrations should be drawn to approximately twice the printed size to obtain satisfactory reproduction. As far as possible, please avoid diagrams made with India ink on white drawing paper, cellophane sheet or tracing paper with hand written captions or titles. Photographs should be on glossy paper. Photographs should bear the names of the authors and the title of the paper on the back, lightly in pencil. Alternatively photographs and photomicrographs can be submitted as jpeg images. Figure and Table titles and legends should be typed on a separate page with numerals corresponding to the illustrations. Keys to symbols, abbreviations, arrows, numbers or letters used in the illustrations should not be written on the illustration itself but should be clearly explained in the legend. Avoid inserting a box with key to symbols, in the figure or below the figure. In case of photomicrographs, magnification should be mentioned either directly on them or in the legend. Symbols, arrows or letters used in photomicrographs should contrast with the background. Method of staining should also be mentioned in the legend.
Chemical terminology: The chemical nomenclature used must be in accordance with that used in the Chemical Abstracts.
Symbols and abbreviations: Unless specified otherwise, all temperatures are understood to be in degrees centigrade and need not be followed by the letter ‘C’. Abbreviations should be those well known in scientific literature. In vitro, in vivo, in situ, ex vivo, ad libitum, et al. and so on are two words each and should be written in italics. None of the above is a hyphenated word. All foreign language (other than English) names and words shall be in italics as a general rule. Words such as carrageenan-induced inflammation, paracetamol-induced hepatotoxicity, isoproterenol-induced myocardial necrosis, dose-dependent manner are all hyphenated.
General Guide lines for units and symbols: The use of the international system of Units (SI) is recommended. For meter (m), gram (g), kilogram (kg), second (s), minute (m), hour (h), mole (mol), liter (l), milliliter (ml), microliter (µl). No pluralization of symbols is followed. There shall be one character spacing between number and symbol. A zero has to be used before a decimal. Decimal numbers shall be used instead of fractions.
Biological nomenclature: Names of plants, animals and bacteria should be in italics.
Enzyme nomenclature: The trivial names recommended by the IUPAC-IUB Commission should be used. When the enzyme is the main subject of a paper, its code number and systematic name should be stated at its first citation in the paper.
Authors involving in the usage of experimental animals and human subjects in their research article should seek approval from the appropriate Institutional Animal Ethics committee in accordance with "Principles of Laboratory Animal Care". The Method section of the manuscript should include a statement to prove that the investigation was approved and that informed consent was obtained.
PROTECTION OF PATIENT’S RIGHTS TO PRIVACY
Care should be taken not to disclose identifying information in the text, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives written informed consent for publication. Authors should remove patients' names from figures unless they have obtained written informed consent from the patients. When informed consent has been obtained, it should be indicated in the manuscript.
A manuscript will be considered for the publication based on the below understanding:
1. All named authors should agree to its submission
2. It is not currently being considered for the publication by another journal
3. If the paper is accepted, it will not be subsequently published in the same or similar form in any language without the consent of publishers Any changes to the author list after submission, viz., a change in the order of the authors, deletion or addition of the authors needs to be approved by a signed letter from each author.
CONFLICT OF INTEREST
A conflict of interest may exist when an author or the author’s institution has a financial or other relationship with other people or organizations that may inappropriately influence the author’s work. A conflict can be actual or potential and full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal may use such information as a basis for the editorial decisions and may publish such disclosures if they are believed to be important to readers while judging the manuscript. A decision may be made by the journal not to publish on the basis of the declared conflict.
Authors are asked to sign a warranty and copyright agreement upon acceptance of their manuscript, before the manuscript can be published. Submission of your paper to this journal implies that the paper is not under submission for publication elsewhere. Material which has been previously copyrighted, published, or accepted for publication will not be considered for publication in this journal. Submission of a manuscript is interpreted as a statement of certification that no part of the manuscript is copyrighted by any other publisher nor is under review by any other formal publication. By submitting your manuscript to us, you agree on IJRHS publication copyright guidelines. It is your responsibility to ensure that your manuscript does not cause any copyright infringements, defamation, and other problems. Submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not responsibility of the IJRHS publications or its Editorial Staff. The main author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the respon sibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
REVIEWING AND PROMPTNESS OF PUBLICATION
All papers submitted for publication are immediately subjected to editorial scrutiny, usually in consultation with members of the journal Editorial Advisory Board and outside independent reviewers. Every effort will be made to peer review submitted papers quickly. Papers which are delayed by authors in revision for more than 30 days will have to be re-submitted as a new submission. Papers accepted for publication are typeset and proofs are dispatched to authors for any corrections prior to final publication.
Authors will receive page proofs of their accepted paper before publications. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 72 hours. Major changes are not acceptable at the proof stage. If unable to send corrections within 72 hours due to some reason, the author(s) must at least send an acknowledgement on receiving the galley proofs or the article will be published exactly as received and the publishers will not be responsible for any error occurring in the published manuscript in this regard.
Only on acceptance of the manuscript after peer review, authors will require to pay web maintenance, evaluation and editor’s peer reviewing fee for which a mail regarding payment details and mode of payment will be communicated to the authors by editor-in-chief of the Journal.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
|Title||:||International Journal of Research in Health Sciences|
|Publisher||:||Atom and Cell Publishers|